Dermatological Drugs Market Size, Share & Trends Analysis Report By Indication (Acne, Psoriasis, Rosacea, Alopecia), By Region, And Segment Forecasts, 2022 - 2028
This report can be delivered to the clients within 3 Business Days
Dermatological Drugs Market Growth & Trends
The global dermatological drugs market size is expected to reach USD 34.9 billion by 2028, expanding at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2028, according to a new report by Grand View Research, Inc. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.
The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin’s pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.
North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.
Dermatological Drugs Market Report Highlights
Dermatological Drugs Market Growth & Trends
The global dermatological drugs market size is expected to reach USD 34.9 billion by 2028, expanding at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2028, according to a new report by Grand View Research, Inc. The global dermatological drugs market is expected to grow due to driving factors such as the availability of medical resources for detecting and treating skin diseases, nutritional deficiency due to unhealthy food habits, increasing awareness when it comes to lifestyle diseases, and increasing pollution levels, and lack of immunity in the population. Additionally, the rising per capita income and the increasing purchasing power are the driving forces in this market.
The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts. Additionally, infected hair follicles cause acne, which starts from the skin’s pores. Acne causes bumps on the face, shoulders, chest, and back in the form of pimples, blackheads, and whiteheads. Acne can be cured, and the appearance of the skin can be improved with effective treatment from dermatologists, contributing to the dermatological drug market.
North America held the largest revenue share of more than 35% in 2021. The U.S. is positively contributing to the growth of the regional market. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth. This region is one of the promising regions to launch new technology in terms of healthcare infrastructure and advanced research and development activities that help innovate and produce the most appropriate drugs to cure cancer. It is observed that in the region, there is a rapid shift in the healthcare industry to consumer-driven from traditional treatment for providing diagnosis and provision-based health services. Additionally, ease of availability of drugs and reimbursement policies for the patient in the healthcare industry contributes to driving the market in the region.
Dermatological Drugs Market Report Highlights
- The psoriasis segment dominated the market in 2021 with a revenue share of over 35.0%. The reason is that psoriasis affects all ages but is most prevalent in adults and contributes to dermatology drug revenue globally
- North America held the largest revenue share of more than 35% in 2021. The presence of well-established pharmaceutical vendors is one of the key factors supporting the market growth
- The acne segment is expected to expand with a CAGR of 10.5% from 2022 to 2028. Acne is a skin condition where dead skin and oil glands of skin glands are clogged, forming spots, pimples, and sometimes cysts
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information or Data Analysis
1.5. Market Formulation & Data Visualization
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Volume price analysis
1.6.3. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
v2.2. Indication Outlook
2.3. Regional Outlook
2.4. Competitive Insights
CHAPTER 3. DERMATOLOGICAL DRUGS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Scenario
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.5. Business Environment Analysis
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6. PESTLE Analysis
3.6.1.1. Political Landscape
3.6.1.2. Environmental Landscape
3.6.1.3. Social Landscape
3.6.1.4. Technology Landscape
3.6.1.5. Economic Landscape
3.6.1.6. Legal Landscape
3.7. Impact of COVID-19
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Consumer Trends and Preferences
4.2. Factors Affecting Buying Decision
4.3. Consumer Product Adoption
4.4. Observations & Recommendations
CHAPTER 5. DERMATOLOGICAL DRUGS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Indication Movement Analysis & Market Share, 2021 - 2028
5.2. Acne
5.2.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.3. Psoriasis
5.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.4. Rosacea
5.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.5. Alopecia
5.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.6. Others
5.6.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
CHAPTER 6. DERMATOLOGICAL DRUGS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Movement Analysis & Market Share, 2021 - 2028
6.2. North America
6.2.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.2.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.2.3. U.S.
6.2.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.2.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3. Europe
6.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.3. Germany
6.3.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.4. France
6.3.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.4.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.5. U.K.
6.3.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.5.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4. Asia Pacific
6.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4.3. China
6.4.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4.4. India
6.4.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.4.2. Market Estimates and Forecast, by Indication2017 - 2028 (USD Million)
6.5. Central & South America
6.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.5.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.5.3. Brazil
6.5.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.5.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.6. Middle East & Africa
6.6.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.6.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.6.3. South Africa
6.6.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.6.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
CHAPTER 7. COMPETITIVE ANALYSIS
7.1. Key Player’s Recent Developments & Their Impact
7.2. Strategic Framework/Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.3. Major Deals & Strategic Alliances Analysis
7.4. Heat Map Analysis/Company Position Analysis
CHAPTER 8. COMPANY PROFILES
8.1. Novartis AG
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Amgen Inc
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. AbbVie Inc
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Johnson & Johnson
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Leo Pharma A/S
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Eli Lilly and Company
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. GlaxoSmithKline Plc
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. AstraZeneca plc
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Pfizer Inc
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Merck KGaA
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.1.1. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information or Data Analysis
1.5. Market Formulation & Data Visualization
1.6. Model Details
1.6.1. Commodity flow analysis
1.6.2. Volume price analysis
1.6.3. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
v2.2. Indication Outlook
2.3. Regional Outlook
2.4. Competitive Insights
CHAPTER 3. DERMATOLOGICAL DRUGS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Scenario
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.5. Business Environment Analysis
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from New Entrant
3.5.1.5. Competitive Rivalry
3.6. PESTLE Analysis
3.6.1.1. Political Landscape
3.6.1.2. Environmental Landscape
3.6.1.3. Social Landscape
3.6.1.4. Technology Landscape
3.6.1.5. Economic Landscape
3.6.1.6. Legal Landscape
3.7. Impact of COVID-19
CHAPTER 4. CONSUMER BEHAVIOR ANALYSIS
4.1. Consumer Trends and Preferences
4.2. Factors Affecting Buying Decision
4.3. Consumer Product Adoption
4.4. Observations & Recommendations
CHAPTER 5. DERMATOLOGICAL DRUGS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Indication Movement Analysis & Market Share, 2021 - 2028
5.2. Acne
5.2.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.3. Psoriasis
5.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.4. Rosacea
5.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.5. Alopecia
5.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
5.6. Others
5.6.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
CHAPTER 6. DERMATOLOGICAL DRUGS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Movement Analysis & Market Share, 2021 - 2028
6.2. North America
6.2.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.2.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.2.3. U.S.
6.2.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.2.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3. Europe
6.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.3. Germany
6.3.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.4. France
6.3.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.4.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.3.5. U.K.
6.3.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.3.5.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4. Asia Pacific
6.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4.3. China
6.4.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.4.4. India
6.4.4.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.4.4.2. Market Estimates and Forecast, by Indication2017 - 2028 (USD Million)
6.5. Central & South America
6.5.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.5.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.5.3. Brazil
6.5.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.5.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.6. Middle East & Africa
6.6.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.6.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
6.6.3. South Africa
6.6.3.1. Market Estimates and Forecast, 2017 - 2028 (USD Million)
6.6.3.2. Market Estimates and Forecast, by Indication, 2017 - 2028 (USD Million)
CHAPTER 7. COMPETITIVE ANALYSIS
7.1. Key Player’s Recent Developments & Their Impact
7.2. Strategic Framework/Competition Categorization (Key Innovators, Market Leaders, Emerging Players
7.3. Major Deals & Strategic Alliances Analysis
7.4. Heat Map Analysis/Company Position Analysis
CHAPTER 8. COMPANY PROFILES
8.1. Novartis AG
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Amgen Inc
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. AbbVie Inc
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Johnson & Johnson
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Leo Pharma A/S
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Eli Lilly and Company
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. GlaxoSmithKline Plc
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. AstraZeneca plc
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Pfizer Inc
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Merck KGaA
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
LIST OF TABLES
Table 1 Dermatological Drugs Market- Key Market Driver Analysis
Table 2 Dermatological Drugs Market- Key Market Restraint Analysis
Table 3 Global Dermatological Drugs Market Estimates and Forecast By Acne, From 2017 - 2028 (USD Million)
Table 4 Global Dermatological Drugs Market Estimates and Forecast By Psoriasis, From 2017 - 2028 (USD Million)
Table 5 Global Dermatological Drugs Market Estimates and Forecast By Rosacea, From 2017 - 2028 (USD Million)
Table 6 Global Dermatological Drugs Market Estimates and Forecast By Alopecia, From 2017 - 2028 (USD Million)
Table 7 Global Dermatological Drugs Market Estimates and Forecast By Others, From 2017 - 2028 (USD Million)
Table 8 Global Dermatological Drugs Market Estimates and Forecast, By Region 2017 - 2028 (USD Million)
Table 9 Global Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 10 North America Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 11 North America Dermatological Drugs Market Revenue Estimates and Forecast, By Indication, 2017 - 2028 (USD Million)
Table 12 U.S. Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 13 U.S. Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 14 Europe Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 15 Europe Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 16 Germany Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 17 Germany Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 18 France Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 19 France Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 20 U.K. Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 21 U.K. Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 22 Asia Pacific Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 23 Asia Pacific Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 24 China Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 25 China Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 26 India Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 27 India Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 28 Central & South America Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 29 Central & South America Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 30 Brazil Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 31 Brazil Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 32 Middle East & Africa Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 33 Middle East & Africa Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 34 South Africa Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 35 South Africa Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 36 Vendor Landscape
Table 1 Dermatological Drugs Market- Key Market Driver Analysis
Table 2 Dermatological Drugs Market- Key Market Restraint Analysis
Table 3 Global Dermatological Drugs Market Estimates and Forecast By Acne, From 2017 - 2028 (USD Million)
Table 4 Global Dermatological Drugs Market Estimates and Forecast By Psoriasis, From 2017 - 2028 (USD Million)
Table 5 Global Dermatological Drugs Market Estimates and Forecast By Rosacea, From 2017 - 2028 (USD Million)
Table 6 Global Dermatological Drugs Market Estimates and Forecast By Alopecia, From 2017 - 2028 (USD Million)
Table 7 Global Dermatological Drugs Market Estimates and Forecast By Others, From 2017 - 2028 (USD Million)
Table 8 Global Dermatological Drugs Market Estimates and Forecast, By Region 2017 - 2028 (USD Million)
Table 9 Global Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 10 North America Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 11 North America Dermatological Drugs Market Revenue Estimates and Forecast, By Indication, 2017 - 2028 (USD Million)
Table 12 U.S. Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 13 U.S. Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 14 Europe Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 15 Europe Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 16 Germany Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 17 Germany Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 18 France Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 19 France Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 20 U.K. Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 21 U.K. Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 22 Asia Pacific Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 23 Asia Pacific Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 24 China Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 25 China Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 26 India Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 27 India Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 28 Central & South America Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 29 Central & South America Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 30 Brazil Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 31 Brazil Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 32 Middle East & Africa Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 33 Middle East & Africa Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 34 South Africa Dermatological Drugs Market Estimates and Forecast, 2017 - 2028 (USD Million)
Table 35 South Africa Dermatological Drugs Market Estimates and Forecast By Indication, 2017 - 2028 (USD Million)
Table 36 Vendor Landscape
LIST OF FIGURES
List of Figures
Fig. 1 Dermatological Drugs Market Snapshot
Fig. 2 Dermatological Drugs Market Segmentation & Scope
Fig. 3 Dermatological Drugs Market Penetration & Growth Prospect Mapping
Fig. 4 Dermatological Drugs Market Value Chain Analysis
Fig. 5 Dermatological Drugs Market Dynamics
Fig. 6 Dermatological Drugs Market Porter's Analysis
Fig. 7 Dermatological Drugs Market: Indication Movement Analysis
Fig. 8 Dermatological Drugs Market: Regional Movement Analysis
List of Figures
Fig. 1 Dermatological Drugs Market Snapshot
Fig. 2 Dermatological Drugs Market Segmentation & Scope
Fig. 3 Dermatological Drugs Market Penetration & Growth Prospect Mapping
Fig. 4 Dermatological Drugs Market Value Chain Analysis
Fig. 5 Dermatological Drugs Market Dynamics
Fig. 6 Dermatological Drugs Market Porter's Analysis
Fig. 7 Dermatological Drugs Market: Indication Movement Analysis
Fig. 8 Dermatological Drugs Market: Regional Movement Analysis
